MAYNE PHARMA GROUP LIMITED — Board/Management Information 2011

Jan 27, 2011

==> picture [115 x 58] intentionally omitted <==

==> picture [131 x 17] intentionally omitted <==

==> picture [194 x 16] intentionally omitted <==

==> picture [135 x 16] intentionally omitted <==

==> picture [187 x 16] intentionally omitted <==

==> picture [110 x 16] intentionally omitted <==

: Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that it has appointed Mr Roger Corbett as Chairman at its recent Board meeting held on the 27[th] January 2011.

Mr Roger Corbett has unparalleled retail and corporate experience both in Australia and internationally. He was previously the CEO of Woolworths and was instrumental in building Woolworths into the dynamic and successful enterprise it is today in Australia. Mr Corbett is currently the Chairman of Fairfax Media Limited, deputy Chairman of PrimeAg Australia, a director of Reserve Bank of Australia and US-based Wal-Mart Stores Inc.

Mayne Pharma Group’s CEO, Dr Roger Aston said “We are delighted with Roger’s acceptance of the Chairman’s role so soon after joining the Mayne Pharma Group Board in November 2010. In addition to the valuable support that he will provide the Board and me, we will also now comply with best practice corporate governance by separating the CEO and Chairman’s roles.”

Mr Corbett said “Mayne Pharma has a very exciting future and I am looking forward to leading the Board at a time of significant change and working closely with Dr Aston to take the Company through the next important stages of its evolution.”

==> picture [43 x 14] intentionally omitted <==

==> picture [188 x 15] intentionally omitted <==

==> picture [106 x 14] intentionally omitted <==

==> picture [107 x 14] intentionally omitted <==

==> picture [67 x 14] intentionally omitted <==

==> picture [251 x 14] intentionally omitted <==

==> picture [18 x 14] intentionally omitted <==

==> picture [21 x 14] intentionally omitted <==

==> picture [137 x 14] intentionally omitted <==

Mayne Pharma Group Limited (Mayne Pharma) is an Australian specialist pharmaceutical company with an intellectual property portfolio built around the optimisation and delivery of oral dosage form drugs.

Mayne Pharma has a long and successful history of developing and commercializing improved pharmaceuticals and has launched and marketed numerous products through partnerships with licensees in various countries around the world. Mayne Pharma focuses on delivering to patients improved versions of existing drugs in order to advance safety, efficacy or ease of administration.

A technology driven company, Mayne Pharma has a significant product portfolio and pipeline, global reach through distribution partners in Australia, USA, Europe and Asia and a manufacturing facility based in Salisbury, South Australia that employs over 150 people on a 32 acre site. The facility also undertakes the manufacture of products under contract for third parties to TGA, FDA and EU regulatory guidelines.